Century Therapeutics Stock Rises on Job Cuts

Dow Jones
2025/07/08
 

By Kelly Cloonan

 

Shares of Century Therapeutics climbed after the company announced plans to cut 51% of its employees and focus on programs with the highest potential for value.

The stock rose 11% to $0.61 in after-hours trading on Monday. Shares have declined 75% in the past 12 months through Monday's close.

The company expects to incur charges of about $3.7 million for severance and other employee termination-related costs as a result of the cuts, according to a filing with the Securities and Exchange Commission on Monday.

The reduction in force will amount to about 77 workers, given the company employed 150 full- and part-time employees as of March 1, according to its latest annual filing.

The company expects the layoffs to be substantially complete by the end of the third quarter.

 

Write to Kelly Cloonan at kelly.cloonan@wsj.com

 

(END) Dow Jones Newswires

July 07, 2025 17:55 ET (21:55 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10